LIVANOVA PLC |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 61.98 USD | +0.90% |
|
-2.68% | +18.73% |
| May. 01 | LivaNova's Q1 Adjusted Earnings, Revenue Rise, Tops Street View; Raises 2024 Guidance | MT |
| May. 01 | Transcript : LivaNova PLC, Q1 2024 Earnings Call, May 01, 2024 |
Chart calendar LivaNova PLC
4d81b96544f7c58bac18abc10d881.PDGQKgTUG8ovB0IOWp9HVEQp3wh_Yw3hT8hmIWVN5YM.agTYe1CwbY9wawdXANUkOAhnpXgxNUSXN6YtFVYHrfROU_5QdIdNkhliJQ~3328a6d5f25131948180bbf822d0981d
Upcoming events on LivaNova PLC
Past events on LivaNova PLC
| 2024-05-01 08:00 am | Q1 2024 Earnings Call |
| 2024-05-01 06:00 am | Q1 2024 Earnings Release |
| 2024-03-12 10:45 am | Barclays Global Healthcare Conference |
| 2024-02-21 08:00 am | Q4 2023 Earnings Call |
| 2024-02-21 06:00 am | Q4 2023 Earnings Release |
| 2023-12-06 | Non Deal Roadshow - Wolfe Research |
| 2023-11-29 08:30 am | Piper Sandler Healthcare Conference |
| 2023-11-14 09:10 am | Stifel Healthcare Conference - Fireside Chat |
| 2023-11-01 08:00 am | Q3 2023 Earnings Call |
| 2023-11-01 06:00 am | Q3 2023 Earnings Release |
| 2023-09-12 12:50 pm | Baird Global Healthcare Conference |
| 2023-07-26 08:00 am | Q2 2023 Earnings Call |
| 2023-07-26 06:00 am | Q2 2023 Earnings Release |
| 2023-06-12 10:00 am | Annual General Meeting |
| 2023-05-03 08:00 am | Q1 2023 Earnings Call |
| 2023-05-03 06:00 am | Q1 2023 Earnings Release |
| 2023-03-16 09:00 am | Barclays Global Healthcare Conference |
| 2023-02-22 08:00 am | FY 2022 Earnings Call |
| 2023-02-22 05:00 am | FY 2022 Earnings Release |
| 2022-12-05 01:00 pm | American Epilepsy Society Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1 084 1 092 -0.73% | 934 938 -0.45% | 1 035 1 032 0.36% | 1 022 1 009 1.24% | 1 154 1 128 2.22% | 1 216 |
|
EBITDA Million USD | Released Forecast Spread | 210 221 -4.82% | 127 128 -1.48% | 179 180 -0.28% | 168 172 -2.52% | 194 199 -2.33% | 248 |
|
EBIT Million USD | Released Forecast Spread | 180 183 -2.05% | 97,5 97,0 0.49% | 155 154 0.27% | 145 140 3.42% | 169 169 0.4% | 220 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -186 -22,7 -718.06% | -344 -34,2 -905.66% | -125 75,0 -266% | -75,1 15,4 -586.18% | -81,2 15,0 -641.33% | 0,00 |
|
Net income Million USD | Released Forecast Spread | -155 77,0 -301.56% | -345 -196 -76.33% | -136 -129 -4.95% | -86,2 -81,0 -6.42% | 17,5 13,2 32.24% | 39,4 |
|
EPS USD | Released Forecast Spread | -3,21 0,81 -497.52% | -7,10 -2,83 -150.52% | -2,68 -2,43 -10.29% | -1,61 -1,51 -6.62% | 0,32 0,36 -12.1% | 0,69 |
| Announcement Date | 26/02/20 | 24/02/21 | 23/02/22 | 22/02/23 | 21/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 240 232 3.73% | 254 250 1.86% | 253 247 2.35% | 275 262 4.86% | 263 243 8.2% | 294 265 10.89% | 286 272 5.03% | 310 288 7.79% | 295 278 6.01% | 305 | 297 | 322 | 308 | 317 |
|
EBITDA Million USD | Released Forecast Spread | 34,0 39,6 -14.03% | 38,9 43,2 -9.88% | 42,1 42,0 0.32% | 52,5 52,3 0.48% | 32,8 32,7 0.38% | 55,5 40,8 35.94% | 51,6 47,2 9.3% | 54,1 56,3 -3.91% | 59,4 42,4 39.98% | 62,3 | 58,6 | 72,0 | 73,0 | 78,0 |
|
EBIT Million USD | Released Forecast Spread | 28,4 34,1 -16.73% | 33,4 34,1 -2.18% | 36,6 34,7 5.6% | 46,8 43,2 8.33% | 26,8 26,5 1.32% | 49,5 34,5 43.66% | 45,0 38,5 17.04% | 48,0 48,0 0% | 53,1 35,1 51.47% | 55,3 | 50,8 | 63,6 | 51,4 | 62,0 |
|
Net income Million USD | Released Forecast Spread | 3,00 9,90 -69.7% | 16,4 3,45 375.36% | -107 10,4 -1131.73% | 1,70 10,2 -83.33% | 7,40 -5,90 225.42% | 1,20 6,15 -80.49% | -7,30 11,0 -166.36% | 16,3 6,23 161.5% | -41,9 0,15 -28033.33% | 16,4 | 14,6 | 25,1 | 23,0 | 27,0 |
|
EPS USD | Released Forecast Spread | 0,06 0,13 -53.85% | 0,30 0,10 190.33% | -2,01 0,21 -1057.14% | 0,03 0,27 -88.89% | 0,14 -0,10 236.59% | 0,02 0,14 -85.19% | -0,14 0,23 -161.76% | 0,30 0,19 60% | -0,78 0,06 -1331.64% | 0,34 | 0,30 | 0,48 | 0,42 | 0,49 |
| Announcement Date | 04/05/22 | 03/08/22 | 02/11/22 | 22/02/23 | 03/05/23 | 26/07/23 | 01/11/23 | 21/02/24 | 01/05/24 | - | - | - | - | - |
| 2024-05-16 02:00 am | CONVATEC GROUP PLC: Q1 2024 Sales and Revenue Release - Trading Update |
| 2024-05-16 | POLY MEDICURE LIMITED: Q4 2024 Earnings Release |
| 2024-05-22 01:00 am | YPSOMED HOLDING AG: Q4 2024 Earnings Release |
| 2024-05-23 06:45 am | MEDTRONIC PLC: Q4 2024 Earnings Release |
| 2024-05-24 08:00 am | MESA LABORATORIES, INC.: Q4 2024 Earnings Release |
| 2024-05-28 05:00 pm | FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED: Q4 2024 Earnings Release |
| 2024-06-18 | PATTERSON COMPANIES, INC.: Q4 2024 Earnings Release (Projected) |
| 2024-06-26 | SCHOTT PHARMA AG & CO. KGAA: Q2 2024 Earnings Release |
| 2024-07-03 | MANI, INC.: Q3 2024 Earnings Release (Projected) |
| 2024-07-11 01:00 am | GERRESHEIMER AG: Q2 2024 Earnings Release |
Past sector events for LivaNova PLC
| Today | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| Today | HOYA CORPORATION: Q4 2023 Earnings Release |
| 2024-05-14 01:00 am | AMBU A/S: Q2 2024 Earnings Release |
| 2024-05-13 | HLB CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-05-13 | TERUMO CORPORATION: Q4 2024 Earnings Release |
| 2024-05-13 | ALFRESA HOLDINGS CORPORATION: Q4 2023 Earnings Release |
| 2024-05-12 | PARAMOUNT BED HOLDINGS CO., LTD.: Q4 2023 Earnings Release |
| 2024-05-10 04:10 pm | ATRION CORPORATION: Q1 2024 Earnings Release |
| 2024-05-09 | NIPRO CORPORATION: Q4 2023 Earnings Release |
| 2024-05-09 | PHC HOLDINGS CORPORATION: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- LIVN Stock
- Calendar LivaNova PLC